secwatch.observer — SEC 8-K summary
======================================

Issuer:     QuidelOrtho Corp (QDEL)
CIK:        0001906324
Form:       8-K
Filed at:   2024-07-31T23:59:59+00:00
Accession:  0001906324-24-000042
Event type: earnings
Sentiment:  negative
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

QuidelOrtho Q2 2024: revenue $637M, GAAP diluted loss ($2.20)/share
-------------------------------------------------------------------

- Total revenue $637M, down 4% YoY; lower COVID-19 revenue was primary driver.
- GAAP diluted loss per share ($2.20) vs ($0.80) prior year; GAAP operating loss ($118M).
- Adjusted diluted loss per share ($0.07) vs +$0.26; adjusted EBITDA $90M (14% margin).
- Announced $100M annualized cost-savings initiatives to benefit H2 2024 and H1 2025.
- Ex-COVID & U.S. Donor Screening, recurring revenue grew 5% constant currency YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1906324/000190632424000042/0001906324-24-000042-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1906324/000190632424000042/qdel-20240731.htm
  HTML page:      https://secwatch.observer/filing/0001906324-24-000042

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer